FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling
about
The emerging role of FTY720 (Fingolimod) in cancer treatmentFingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma.FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism.Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabine.Sphingosine kinase 1 is overexpressed and promotes adrenocortical carcinoma progressionValosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signalingEffects of long term low- and high-dose sodium arsenite exposure in human transitional cells.Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathwaysThe antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells.Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway.Signaling pathways and mesenchymal transition in pediatric high-grade glioma.FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.Adverse Effect Profile of Topical Ocular Administration of Fingolimod for Treatment of Dry Eye Disease.
P2860
Q26748927-FCCAF3D0-B33D-4096-B1FC-99BB80B1D8D6Q28068032-F3709185-8368-4F28-84D9-1D5037FF9B1AQ33813952-6AAF564B-3646-43E8-9E6D-C81D60DBD8F3Q33912023-9413A7D2-4141-47A8-A120-99A5BB652752Q35108555-E3F78C55-FA17-426F-BBC3-01F0BE5C0B28Q36502644-3F7E73BC-9669-4FD7-A262-6B11ADEE1781Q36772101-6C4DDFBF-2704-4257-BB74-9231680BC012Q37053461-F93ACA10-57C6-424E-8DD0-722ADC2B503CQ37685225-5216CB5D-25E7-4AD4-8B74-8012B9507F2CQ37718328-62013A4D-C14E-4B63-BF4E-872753D17F3BQ38546700-22B03671-D299-4999-8E62-E98E81E6A5ACQ41893260-A14B58CC-2845-46EA-AB4A-27B55DA80F79Q47096604-7C7FF81E-14B8-4151-B15E-198EFC0D7346Q48258004-EE0D9E64-5A0B-44C6-B9F8-E027B926BC8AQ52714457-38419ECD-C078-4F30-96C0-B7536854AD4EQ52820593-1BA4F82B-69F9-4A32-9845-E3EDB3C3FBD8
P2860
FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@ast
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@en
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@nl
type
label
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@ast
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@en
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@nl
prefLabel
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@ast
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@en
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@nl
P2093
P2860
P356
P1433
P1476
FTY720 inhibits proliferation ...... y inactivating STAT3 signaling
@en
P2093
Dalong Yin
Jiabei Wang
Lianxin Liu
Ruipeng Song
Shangha Pan
Tiemin Pei
Tongsen Zheng
Yingjian Liang
Zhaoyang Lu
P2860
P2888
P356
10.1186/1471-2407-14-783
P407
P577
2014-10-25T00:00:00Z
P5875
P6179
1046319029